DFC committed a $20 million loan to Panacea Biotec Ltd. to help the company expand production of its “six-in-one” hexavalent vaccine that protects against diphtheria, tetanus, polio, pertussis, hepatitis B, and Haemophilus influenzae type B.
Hewa Tele is using a $10 million DFC loan to expand production and distribution of oxygen. Hewa Tele’s model is based on decentralizing oxygen production, reducing costs, improving reliability, and increasing accessibility.
Ukraine’s non-profit Superhumans Center, backed by $25 million in political risk insurance from DFC, is supporting the country’s life-saving work to care for those who were injured during Russia’s brutal invasion.